Tag: interferon
Alemtuzumab vs. interferon en EM remitente-recidivante
Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS
Mejorar la fatiga haciendo ejercicio
New evidence that exercise could reduce patients’ blood interferon level and fatigue
El cambio a fármacos modificadores de la enfermedad de segunda línea
Study shows that switching to natalizumab is more effective than switching to fingolimod
Los fármacos modificadores de la enfermedad podrían reducir el avance de la discapacidad en la EM recurrente-remitente
Researchers found a lower risk of disability progression at the 10-year follow-up in the RRMS group compared with historical cohorts
Resultados positivos al cambiar del interferón al Copaxone
Switching patients with relapsing-remitting MS from interferon to glatiramer acetateis associated with positive treatment outcomes